Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Miromatrix Medical Inc (NQ: MIRO )

1.310 UNCHANGED
Streaming Delayed Price Updated: 3:26 PM EDT, Sep 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Miromatrix Medical Inc

Miromatrix Announces Participation in H.C. Wainwright Global Investment Conference
From Miromatrix Medical Inc.
Via GlobeNewswire
Miromatrix Announces Participation in the ARM Tissue Engineering and Therapeutics Workshop
From Miromatrix Medical Inc.
Via GlobeNewswire
Miromatrix Reports Second Quarter 2023 Results and Provides Corporate Update
From Miromatrix Medical Inc.
Via GlobeNewswire
Miromatrix to Report Second Quarter 2023 Financial Results
From Miromatrix Medical Inc.
Via GlobeNewswire
Miromatrix Poster Voted Best in Congress at the 2023 American Transplant Congress; Jack Lake Wins Lifetime Achievement Award
From Miromatrix Medical Inc.
Via GlobeNewswire
Miromatrix Announces CEO Jeff Ross, Ph.D. will Expand His Role by Resuming Leadership of R&D
From Miromatrix Medical Inc.
Via GlobeNewswire
Miromatrix Presenting at the 2023 American Transplant Congress
From Miromatrix Medical Inc.
Via GlobeNewswire
Miromatrix Announces Participation in the 20th Annual Craig-Hallum Institutional Investor Conference
From Miromatrix Medical Inc.
Via GlobeNewswire
Miromatrix Reports First Quarter 2023 Results and Provides Corporate Update
From Miromatrix Medical Inc.
Via GlobeNewswire
Miromatrix to Report First Quarter 2023 Financial Results
From Miromatrix Medical Inc.
Via GlobeNewswire
Miromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene Meeting on the Med
From Miromatrix Medical Inc.
Via GlobeNewswire
CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation
From CareDx, Inc.
Via Business Wire
CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation
From Miromatrix Medical Inc.
Via GlobeNewswire
Miromatrix Reports Fourth Quarter and Full Year 2022 Results and Provides Corporate Update
From Miromatrix Medical Inc.
Via GlobeNewswire
Miromatrix to Report Fourth Quarter and Full Year 2022 Financial Results
From Miromatrix Medical Inc.
Via GlobeNewswire
Miromatrix Medical Inc. Announces Pricing of $10 Million Public Offering of Common Stock
From Miromatrix Medical Inc.
Via GlobeNewswire
Miromatrix Medical Inc. Announces Proposed Public Offering of Common Stock
From Miromatrix Medical Inc.
Via GlobeNewswire
Miromatrix and Baxter Announce Collaborative Research Agreement Aiming to Advance Care for Patients with Acute Liver Failure
From Miromatrix Medical Inc.
Via GlobeNewswire
Miromatrix Provides Update on miroliverELAP
From Miromatrix Medical Inc.
Via GlobeNewswire
Miromatrix Announces FDA Clinical Hold on IND Application for miroliverELAP
From Miromatrix Medical Inc.
Via GlobeNewswire
Miromatrix Announces Participation in the Piper Sandler 34th Annual Healthcare Conference
From Miromatrix Medical Inc.
Via GlobeNewswire
Miromatrix Reports Filing of IND, Third Quarter 2022 Results, and Provides Corporate Update
From Miromatrix Medical Inc.
Via GlobeNewswire
Miromatrix to Report Third Quarter 2022 Financial Results
From Miromatrix Medical Inc.
Via GlobeNewswire
Miromatrix CEO Jeff Ross Delivering Keynote Address at ARMI | BioFabUSA 2022 Fall Summit: Meeting in the Millyard
From Miromatrix Medical Inc.
Via GlobeNewswire
Miromatrix CEO Jeff Ross to Present at the 2022 Cell & Gene Meeting on the Mesa
From Miromatrix Medical Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.